FTSE MIB
34.431,50 -238,56 (-0,69%) Dow Jones
38.649,01 +77,98 (+0,20%) Nasdaq
16.824,05 -4,62 (-0,03%) Nikkei 225
38.837,46 -85,54 (-0,22%) Petrolio
72,81 -1,41 (-1,90%) Bitcoin EUR
64.029,25 -213,48 (-0,33%)
Yield10 Bioscience, Inc. (YTEN)
| Chiusura precedente | 1,9100 |
| Aperto | 1,9100 |
| Denaro | 0,0000 x 0 |
| Domanda | 0,0000 x 0 |
| Min-Max giorno | 1,8090 - 1,9100 |
| Intervallo di 52 settimane | 1,8000 - 67,9200 |
| Volume | |
| Media Volume | 174.438 |
| Capitalizzazione | 1,169M |
| Beta (mensile su 5 anni) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -30,2900 |
| Prossima data utili | 12 ago 2024 - 16 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 2,50 |
GlobeNewswireYield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025 -First field tests of stacked herbicide tolerant winter Camelina underway -Recent positive field tests demonstrate stacked herbicide traits in spring Camelina -Herbicide tolerance in Camelina supports large acreage production of low-carbon intensity feedstock oil for the biofuel market WOBURN, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”),
- GlobeNewswire
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platformWOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the harvest of a majority of the winter and spring Camelina sativa ("Camelina”) grain produced under grower contracts in 2022/2023 has been completed. This harvest marks the establishment of the Company’s “Camelina Seed Genetics to Biofuel” platform,
- GlobeNewswire
Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference
WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11-13, 2023, at the Lotte New York Palace Hotel. President and Chief Executive Officer Oliver Peoples, Ph.D. will present a corporate overview that will also include a business update. The presentation will
